Introducing the Ultragenyx LC-FAOD Disease Monitoring Programs: Our Commitment to Advancing LC-FAOD Research Globally

August 25, 2021 • 00:59:38
Introducing the Ultragenyx LC-FAOD Disease Monitoring Programs: Our Commitment to Advancing LC-FAOD Research Globally
MitoAction Expert Series
Introducing the Ultragenyx LC-FAOD Disease Monitoring Programs: Our Commitment to Advancing LC-FAOD Research Globally

Aug 25 2021 | 00:59:38

/

Show Notes

Join MitoAction, Laura Pisani-Betancourt and Kristin Voorhees from Ultragenyx Pharmaceutical on Friday, July 9th, 2021 at 12:00pm EST for our monthly expert series presentation!

On this webinar, Ultragenyx will discuss the development of its LC-FAOD Disease Monitoring Program (DMP), which includes both an in-clinic study and an online study that are expected to launch in 2021. Participants will learn about the studies, including how insights from the LC-FAOD community have informed the DMP’s research goals, how the DMP aims to change the future of LC-FAOD research and disease management, and Ultragenyx’s plans to launch the DMP.

*This webinar is intended for U.S. members of the MitoAction community*

Other Episodes

Episode

September 03, 2026 • 00:45:35
Episode Cover

Eat Smart, Power Strong: Your Mitochondrial Nutrition Grade

If you were to grade your knowledge of nutrition and meal planning and preparation, would you pass?  This presentation will explain the basic nutrition...

Listen

Episode

June 23, 2022 • 01:10:33
Episode Cover

Service Dogs for Children and Adults with Mito

How can a service dog help a child or adult patient with mitochondrial disease? Learn more and ask questions, such as: How can service...

Listen

Episode

August 18, 2022 • 01:02:07
Episode Cover

Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from...

Listen